Reproductive Biology and Endocrinology is calling for submissions to our Collection on Endometriosis: Advances in Disease Mechanisms, Diagnosis and Management. This collection aspires to assemble pioneering research on endometriosis, covering a comprehensive range of topics, including its complex pathophysiology, significant clinical implications, and innovative multidisciplinary management approaches. We invite researchers across various fields to contribute their valuable work on critical areas such as genetic and epigenetic factors that influence the disease development, the mental health implications faced by individuals living with endometriosis, and the latest innovations in pain mechanisms and pain management.

We are particularly interested in studies focused on

• early and non-invasive diagnostic methods that can enhance detection and treatment outcomes

• strategies for fertility preservation that are acquiring importance for women affected by this condition

• analyses of IVF outcomes for patients with endometriosis, as understanding these results is essential for developing effective treatment plans and guiding patients in their reproductive choices.

Our primary aim is to advance our understanding of endometriosis and to improve the quality of care and outcomes for all individuals affected by this often debilitating condition. By bringing together diverse insights and research, this collection seeks to foster collaboration and drive forward the discourse in this vital area of women's health.

We recognize that many key stakeholders may not have access to such resources and are committed to supporting participation in this issue wherever resources are a barrier. For more information about what support may be available, please visit OA funding and support, or email OAfundingpolicy@springernature.com or contact the Editor-in-Chief.

This collection aims to explore the multifaceted impact of private equity (PE) involvement in IVF clinic operations. The rationale behind this investigation is to understand how the infusion of PE capital influences various aspects of fertility treatments, including patient care, research quality, and overall clinic performance. By examining both the positive and negative outcomes, this collection seeks to provide a balanced perspective on the role of PE in the healthcare sector.

We invite submissions of original research articles and review papers addressing issues such as:

• Assessment of the metrics used to measure patient care and research quality in IVF clinics under PE management. This includes key performance indicators (KPIs), patient satisfaction surveys, and clinical outcomes

• The role of PE in providing financial stability and enabling technological advancements in IVF clinics.

• Potential in patient care and research quality due to profit-driven motives.

• Mixed reactions from patients and healthcare providers regarding the corporate approach to fertility treatments

• Examination of how PE influences the cost of IVF treatments and how it affects equity in access to fertility care.

By exploring these topics, this collection aims to offer a comprehensive understanding of the implications of PE involvement in IVF clinics, highlighting both the benefits and challenges associated with this model.

This Collection supports and amplifies research related to SDG 3, Good Health and Well-Being and SDG 10, Reduced Inequalities.

We recognize that many key stakeholders may not have access to such resources and are committed to supporting participation in this issue wherever resources are a barrier. For more information about what support may be available, please visit OA funding and support, or email OAfundingpolicy@springernature.com or contact the Editor-in-Chief.